Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors

Demiraran S., OSMANİYE D., ÖZKAY Y., KAPLANCIKLI Z. A., Koçyiğit-Kaymakçıoğlu B., TOK F.

Journal of Molecular Structure, cilt.1296, 2024 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 1296
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1016/j.molstruc.2023.136903
  • Dergi Adı: Journal of Molecular Structure
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Chemical Abstracts Core, Chimica, Compendex, INSPEC
  • Anahtar Kelimeler: Aromatase, HSQC, MCF-7, NIH3T3 and molecular docking, Thiadiazole
  • Marmara Üniversitesi Adresli: Evet

Özet

In this study, some new thiosemicarbazide and their corresponding 1,3,4-thiadiazole derivatives containing pyridine nuclei were synthesized. Their structures were established based on FT-IR, 1HNMR, 13CNMR, 2D-NMR (HSQC) spectral data and elemental analysis. The MCF-7 and NIH3T3 cells were used to test the compound's anticancer effects. Among the compounds; 4a, 4b, 4d and 4g showed the most potent cytotoxic activity against MCF-7 at IC50 of 3.102±0.096 μM, 8.737±0.103 μM, 11.190±0.088 μM and 12.630±0.101 μM, respectively.Their inhibitory activity was assessed against the in vitro aromatase enzyme. Compounds 4a, 4b, 4d and 4g exhibited the promising aromatase inhibition activity with IC50 value of 0.027±0.002 µM, 0.068±0.005 µM, 1.456±0.009 µM and 3.316±0.001 µM, respectively (the standard drug letrazole has an IC50 value of 0.023±0.002 μM). The molecular docking studies were used to identify the key molecular interactions between the compounds 4a, 4b, 4d and 4g and the aromatase enzyme. Additionally, the physicochemical, druglikeness and pharmacokinetic properties of compounds were also evaluated.